OTOLITH LABS
Otolith Labs has developed a novel wearable medical device that is on track to be the first FDA approved device for the treatment of vertigo through the De Novo process in 2023. The technology provides immediate relief of symptoms in approximately 80% of vertigo cases based on pilot clinical data. Otolith Labs has received $1.8 million in contracts from the US Department of Defense to further develop the technology for their personnel needs.
OTOLITH LABS
Industry:
Consumer Electronics Hardware Medical Medical Device Military Therapeutics
Founded:
2015-01-15
Address:
Washington, District Of Columbia, United States
Country:
United States
Website Url:
http://www.otolithlabs.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
25.74 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Google Maps WordPress 6.0
Current Employees Featured
Founder
Investors List
Morningside Venture Partners
Morningside Venture Partners investment in Series A - Otolith Labs
Radical Investments LP
Radical Investments LP investment in Seed Round - Otolith Labs
Official Site Inspections
http://www.otolithlabs.com Semrush global rank: 5.62 M Semrush visits lastest month: 1.5 K
- Host name: 57.0.153.160.host.secureserver.net
- IP address: 160.153.0.57
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
